The global pharmaceutical industry experienced a 10% drop in new job postings related to cell & gene therapy in Q2 2024 compared with the previous quarter, according to GlobalData’s Job Analytics. This compares to a 19% decrease versus Q2 2023. GlobalData’s Pharma: Hiring Trends & Signals Q2 2024 report reveals comprehensive insights into hiring patterns, job roles, required skills, geographical trends, and key themes within the pharmaceuticals industry, facilitating anticipation of future workforce needs. Buy the report here.
Smarter leaders trust GlobalData
Notably, Management Occupations jobs accounted for a 27% share of the global pharmaceutical industry’s cell & gene therapy-related total new job postings in Q2 2024, down 10% over the prior quarter.
Management Occupations drive cell & gene therapy-related hiring activity
Management Occupations, with a share of 27%, emerged as the top cell & gene therapy-related job roles within the pharmaceutical industry in Q2 2024, with new job postings drop by 10% quarter-on-quarter. Life, Physical, and Social Science Occupations came in second with a share of 23% in Q2 2024, with new job postings rising by 13% over the previous quarter.
The other prominent cell & gene therapy roles include Computer and Mathematical Occupations with a 4% share in Q2 2024, Healthcare Practitioners and Technical Occupations with a 3% share of new job postings.
Top five companies in pharmaceutical industry accounted for 52% of hiring activity
The top companies, in terms of number of new job postings tracked by GlobalData, as of Q2 2024 were Bristol-Myers Squibb, Ferring Pharmaceuticals, AstraZeneca, Genscript Biotech, and WuXi AppTec. Together they accounted for a combined share of 52% of all cell & gene therapy-related new jobs in the pharmaceutical industry.
Bristol-Myers Squibb posted 1,146 cell & gene therapy-related new jobs in Q2 2024, Ferring Pharmaceuticals 222 jobs, AstraZeneca 153 jobs, Genscript Biotech 121 jobs, and WuXi AppTec 99 jobs, according to GlobalData’s Job Analytics.
Hiring activity was driven by the US with a 76.81% share of total new job postings, Q2 2024
The largest share of cell & gene therapy-related new job postings in the pharmaceutical industry in Q2 2024 was in the US with 76.81% followed by India (5.60%) and the UK (3.80%). The share represented by the US was six percentage points higher than the 71.30% share it accounted for in Q1 2024.
For further understanding of GlobalData's Pharma: Hiring Trends & Signals Q2 2024, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Jobs Analytics uses machine learning to uncover key insights from tracking daily job postings for thousands of companies globally. Proprietary analysis is used to group jobs into key thematic areas and granular sectors across the world’s largest industries. classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
